Free Trial

vTv Therapeutics (VTVT) Earnings Date, Estimates & Call Transcripts

$27.40
-0.81 (-2.87%)
(As of 09:50 AM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(Mar. 13)
-$1.67 Missed By -$1.67
Skip Charts & View Estimated and Actual Earnings Data

VTVT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VTVT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

VTVT Earnings Date and Information

vTv Therapeutics last posted its quarterly earnings data on March 13th, 2024. The biotechnology company reported ($1.67) EPS for the quarter. vTv Therapeutics has generated ($8.84) earnings per share over the last year (($8.84) diluted earnings per share). vTv Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.

vTv Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2024
(Estimated)
------- 
3/13/2024Q4 2023-($1.67)($1.67)($1.67)--
11/9/2023Q3 2023-($3.20)($3.20)($3.20)--
8/11/2023Q2 2023-($2.80)($2.80)($0.07)--
5/11/2023Q1 2023($3.20)($2.40)+$0.80($0.06)--
3/6/2023-($2.40)($2.40)-($0.06)-$0.01 million
11/10/2022Q3 2022($2.00)($2.00)-($0.05)--
8/15/2022Q2 2022($4.00)($1.60)+$2.40($0.04)-$0.01 million
5/12/2022Q1 2022($3.20)($4.00)($0.80)($0.10)-$2.00 million
3/29/2022Q4 2021($3.20)($3.20)-($0.05)$1.00 million$0.01 million
11/9/2021Q3 2021($2.80)($0.80)+$2.00($0.02)$1.30 million$3.00 million
8/4/2021Q2 2021($2.80)($0.40)+$2.40($0.01)$1.00 million$0.01 million
5/5/2021Q1 2021($2.40)($3.60)($1.20)($0.10)$0.80 million$0.99 million
2/24/2021Q4 2020($2.40)$0.80+$3.20$0.02$3.30 million$6.40 million
11/5/2020Q3 2020($4.40)($1.20)+$3.20($0.03)-$0.01 million  
8/3/2020Q2 2020($4.00)($3.20)+$0.80($0.09)--
5/7/2020Q1 2020($4.00)($4.40)($0.40)($0.11)-$0.01 million
2/20/2020Q4 2019($4.00)($4.40)($0.40)($0.09)$1.26 million$0.01 million
10/30/2019Q3 2019($4.40)($4.00)+$0.40($0.07)$1.69 million$0.01 million
7/31/2019Q2 2019($4.40)($3.60)+$0.80($0.08)$1.63 million$1.83 million

vTv Therapeutics Earnings - Frequently Asked Questions

When is vTv Therapeutics's earnings date?

vTv Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on VTVT's earnings history.

How much revenue does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded annual revenue of $2.02 million.

How much profit does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded net income of -$20.25 million. VTVT has generated -$8.84 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:VTVT) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners